Cenduit
Cenduit provides cloud-based Interactive Response Technology (IRT) for patient randomization and clinical trial drug supply management, serving pharmaceutical sponsors, biotechs, and CROs; now marketed under IQVIA's clinical technology portfolio.
- Company typePublic
- Founded2007
- HeadquartersDurham, United States
- Headcount251–500
- GTM typeB2B
- OfferingSoftware
What Cenduit does
Cenduit, LLC is a Durham, North Carolina-based clinical trial technology provider founded in 2007 that delivers customized patient randomization and drug supply management solutions to the pharmaceutical and biotech sectors. Its core offering is a cloud-based modular Randomization and Trial Supply Management (RTSM) system built on Interactive Response Technology (IRT), used by pharmaceutical sponsors and Contract Research Organizations (CROs) to assign treatments, manage investigational product (IP) supply chains, and maintain regulatory/audit compliance across trial phases. The company serves complex use cases including precision medicine, adaptive and decentralized trials, early-phase studies, and cell and gene therapy protocols requiring temperature-excursion management and kit traceability.
The platform is organized around configurable components: a Study Designer prototyping tool for rapid study build-out, a pre-built module library for simple-to-complex protocol adaptation, a mobile IP extension, and predictive algorithms for automated forecasting and resupply with direct-to-patient dispensation workflows. Technical differentiation centers on customizability and an integration surface cited at 400+ turnkey eClinical and drug-supply connections (eConsent, eCOA, site portal, DCT platforms). The supporting source material is served entirely under IQVIA branding, and the legal entity is identified as IQVIA Inc. (NYSE: IQV), indicating Cenduit now operates as an IRT solution within IQVIA's clinical technology portfolio rather than as a standalone brand.
The business model is enterprise B2B subscription/recurring: cloud-based RTSM delivered as a service bundled with expert consulting, study design, and ongoing support, sold via a sales-led, field/enterprise motion (demo requests, dedicated customer service, direct outreach) to large pharma sponsors and CROs. Pricing is quote-based and not publicly disclosed. Distribution is global, leveraging IQVIA's footprint across the Americas, Europe, Asia Pacific, and Middle East & Africa, with marketing driven by thought-leadership content, webinars, white papers, earned media, and customer case studies.
Cenduit firmographics
Firmographics- Name
- Cenduit
- Legal name
- IQVIA Inc.
- Website
- https://cenduit.com
- Company type
- Public
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Cenduit provides cloud-based Interactive Response Technology (IRT) for patient randomization and clinical trial drug supply management, serving pharmaceutical sponsors, biotechs, and CROs; now marketed under IQVIA's clinical technology portfolio.
- Ownership category
- akta.pro rank
Cenduit industry classification
Industry- Product category
- Clinical Trial RTSM / Interactive Response Technology Software
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS) (HLACAOAC)
- akta.pro secondary industry
- Clinical Trial Pharmacy & IMP Management at Site (HLAGACAK)
Keywords
Where Cenduit is headquartered
LocationHeadquarters
- HQ city
- Durham
- HQ country
- United States
- HQ region
- North America
Markets served
Cenduit business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- IRT Software Licensing and Services: Cloud-based randomization and trial supply management solution provided as a service to pharmaceutical sponsors and CROs conducting clinical trials. The solution includes platform access, expert consulting services, and ongoing support for study design and deployment.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Cenduit product offering
Product offeringCore offering
Cenduit provides a cloud-based Interactive Response Technology (IRT) / Randomization and Trial Supply Management (RTSM) platform that delivers customized patient randomization and investigational product (drug) supply management for clinical trials. The solution supports simple to complex protocols including precision medicine, adaptive, decentralized, and cell and gene therapy trials, combining study design tools, automated forecasting and resupply, traceability/temperature excursion management, and 400+ integrations with eClinical and drug supply systems for pharmaceutical sponsors, CROs, and biotech companies.
Differentiator
Problem solved
Functional benefit
Products and services
- IRT (Interactive Response Technology) / RTSM Platform Cloud-based Interactive Response Technology / Randomization and Trial Supply Management platform that delivers customized patient randomization, investigational product (IP) supply management, automated forecasting and resupply, and traceability with 400+ eClinical integrations for pharmaceutical sponsors, CROs, and biotechnology companies running clinical trials across all phases and complexity levels.
Quantifiable outcome
- Save upwards of $20,000 a month through automated supply optimization
- +2 more outcomes
Companies that use Cenduit
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Cenduit technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Cenduit partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights5 records
Cenduit competitors and assessment
Company assessmentDirect peers
- Medidata (Dassault Systèmes): Medidata's RTSM/IRT module is part of the broader Medidata Platform and directly competes with Cenduit for enterprise pharma sponsor trials, particularly large Phase II/III programs.
- Signant Health: Signant Health (formed from CRF Health and Bracket) provides RTSM alongside eCOA and eConsent, with comparable focus on complex trial designs and patient-centric workflows.
- Veeva Systems: Veeva Vault Clinical Suite includes randomization and trial supply capabilities and competes head-to-head with Cenduit for enterprise pharma and biotech sponsors running complex protocols.
- Oracle Health Sciences (4G Clinical): Oracle acquired 4G Clinical to add a leading RTSM solution to its Clinical One platform, directly competing with Cenduit across enterprise sponsor and CRO RFPs.
- Suvoda: Suvoda is an IRT-specialist competing directly with Cenduit in randomization and trial supply management, with strong penetration in oncology and rare disease trials.
- Almac Group: Almac's IXRS IRT platform competes directly with Cenduit and is frequently compared head-to-head in sponsor evaluations for randomization and clinical supply chain management.
- Clario: Clario (formerly ERT/Bioclinica) provides clinical trial technology including randomization and supply management, competing with Cenduit across both large pharma and biotech segments.
- Medrio: Medrio's eClinical platform includes randomization and trial supply modules, often competing with Cenduit for mid-sized biotech and emerging sponsor customers.
Broad incumbents
- Parexel International: Parexel is a global CRO with its own IRT/RTSM offering (Perceptive MyTrials), competing with Cenduit as part of bundled full-service trial execution versus standalone RTSM.
- ICON plc: ICON is a top global CRO offering integrated RTSM within its full-service trial delivery, competing with Cenduit for both sponsor-direct contracts and CRO-mediated deployments.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
Cenduit social profiles
Digital presenceCenduit financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cenduit leadership team
Management profileNumber of profiles
Cenduit funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cenduit M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cenduit
What does Cenduit do?
Cenduit provides a cloud-based Interactive Response Technology (IRT) / Randomization and Trial Supply Management (RTSM) platform that delivers customized patient randomization and investigational product (drug) supply management for clinical trials. The solution supports simple to complex protocols including precision medicine, adaptive, decentralized, and cell and gene therapy trials, combining study design tools, automated forecasting and resupply, traceability/temperature excursion management, and 400+ integrations with eClinical and drug supply systems for pharmaceutical sponsors, CROs, and biotech companies.
Is Cenduit a public or private company?
Cenduit is a public company. It is classified as corporate owned and is currently operating.
When was Cenduit founded?
Cenduit was founded in 2007. It employs 251 to 500 people.
Where is Cenduit based?
Cenduit is headquartered in Durham, United States, in the North America region.
How does Cenduit make money?
One revenue line is on record: IRT Software Licensing and Services.
Who are Cenduit's main competitors?
Direct peers on record are Medidata (Dassault Systèmes), Signant Health, Veeva Systems, Oracle Health Sciences (4G Clinical), Suvoda, Almac Group, Clario and Medrio. Broad incumbents are Parexel International and ICON plc.
Does Cenduit have an API?
No public API is recorded for Cenduit.
What industry is Cenduit in?
Cenduit's product category is Clinical Trial RTSM / Interactive Response Technology Software. Its primary akta.pro industry code is HLACAOAC, Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS), with a secondary code of HLAGACAK, Clinical Trial Pharmacy & IMP Management at Site. Its NAICS code is 54151 and its SIC code is 7372.